SHC· Health Care› Diagnostics & Research

Sotera Health Company

Stage 2 · Advancing · week 14

As of Oct 22, 2026, Sotera Health is in Stage 2, the uptrend phase, now in week 14 (since Jul 17, 2026). It closed at $18.13, 7.4% below its 52-week high and above its 200-day average, which is rising.

$18.13

+2.03% today

$5.2B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 32 in Diagnostics & Research · #1 of 272 in Health Care

Is SHC early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 15w

S2 27w

S2 14w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 4w → S3 3w → S4 11w → S1 7w → S2 3w → S1 1w → S4 15w → S1 9w → S2 12w → S3 9w → S4 5w → S1 1w → S4 11w → S1 8w → S4 3w → S1 1w → S2 27w → S3 5w → S4 7w → S1 7w → S2 14w current

Total tracked: 165 weeks across 21 stage runs.

SHC among Diagnostics & Research25th of 44 by relative strength

All 44 →

Stocks in Diagnostics & Research ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CDNACareDx, Inc.	Stage 2 · wk 24	99	+27.3%
2	BDSXBiodesix, Inc.	Stage 2 · wk 18	98	−18.3%
3	ILMNIllumina, Inc.	Stage 2 · wk 24	97	+5.5%
4	GHGuardant Health, Inc.	Stage 2 · wk 21	97	−7.6%
5	NTRANatera, Inc.	Stage 2 · wk 20	96	+2.7%
6	CRLCharles River Laboratories International, Inc.	Stage 2 · wk 16	92	+22.5%
7	RVTYRevvity, Inc.	Stage 2 · wk 18	90	+10.7%
8	PSNLPersonalis, Inc.	Stage 2 · wk 17	90	−3.2%
…25	SHCSotera Health Company	Stage 2 · wk 14	62	−0.9%

vs 52W High

-7.4%

$13.13 lo$19.57 hi

7.4% below 52W high, pullback range

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 14

1w13w26w

Week 14, proven structure

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

6.5%

200 DMA: $17.02 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

1.32x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-0.9%

+4.5%

+18.3%

YTD

+2.5%

+9.1%

Scan Membership

Breakout Watch

Latest: 2024-08-30

5 appearances in last 60 days. First seen: 2021-10-19.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 14 · Vol 1.32x

2026-10-21S2

Wk 14 · Vol 1.26x

2026-10-20S2

Wk 14 · Vol 0.83x

2026-10-19S2

Wk 14 · Vol 0.73x

2026-10-16S2

Wk 13 · Vol 0.81x

2026-10-15S2

Wk 13 · Vol 1.06x

2026-10-14S2

Wk 13 · Vol 0.99x

2026-10-13S2

Wk 13 · Vol 0.72x

2026-10-12S2

Wk 13 · Vol 0.68x

2026-10-09S2

Wk 12 · Vol 0.69x

2026-10-08S2

Wk 12 · Vol 0.96x

2026-10-07S2

Wk 12 · Vol 0.67x

Moving averages & range

50 DMA

$18.58

200 DMA

$17.02

52W High

$19.57

52W Low

$13.13

5D Low

$17.64

Resistance levels (recent highs)

20d High

$18.60

60d High

$19.57

120d High

$19.57

250d High

$19.57

Next resistance

+2.6%

to 20d High

P/E (TTM)

31.8

Forward 16.9

Earnings Growth (YoY)

+569.5%

Revenue +9.2%

ROE

+27.8%

Profit margin +13.4%

Dividend Yield

0.00%

P/B 7.8

Sotera Health: quick answers

What stage is Sotera Health in?

As of Oct 22, 2026, Sotera Health (SHC) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 17, 2026 and is in week 14. What the four stages mean

Is Sotera Health in an uptrend?

Yes. Sotera Health is in a Stage 2 uptrend. It trades 6.5% above its 200-day average, which is rising.

How far is Sotera Health from its 52-week high?

Sotera Health closed at $18.13 on Oct 22, 2026, 7.4% below its 52-week high of $19.57. Its 52-week low is $13.13.

How has Sotera Health performed over the past year?

As of Oct 22, 2026, Sotera Health is up 9.1% over the past year and up 2.5% so far in 2026.

Which sector and industry is Sotera Health in?

Sotera Health is in the Diagnostics & Research industry, part of the Health Care sector.

About this companyHealth Care· Diagnostics & Research

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.